Transradial intervention (TRI) and bivalirudin infusion compared with transfemoral coronary intervention or unfractionated heparin plus glycoprotein IIb/IIIa inhibitors decrease bleeding complications in patients with acute coronary syndromes (ACS). Although bleeding is thought to be associated with worse outcomes, it remains unclear whether TRI and bivalirudin both independently lower ischemic or combined ischemic and bleeding complications in ACS patients undergoing contemporary invasive management.
Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program / Valgimigli, M; Gagnor, A; Calabrò, P; Rubartelli, P; Garducci, S; Andò, G; Santarelli, A; Galli, M; Garbo, R; Bramucci, E; Ierna, S; Briguori, C; Cortese, B; Limbruno, U; Violini, R; Presbitero, P; de Cesare, N; Sganzerla, P; Ausiello, A; Tosi, P; Sardella, G; Sabate, M; Brugaletta, S; Saccone, G; Vandoni, P; Zingarelli, A; Liso, A; Rigattieri, S; Di Lorenzo, E; Vigna, C; Palmieri, C; Falcone, C; De Caterina, R; Caputo, M; Esposito, G; Lupi, A; Mazzarotto, P; Varbella, F; Zaro, T; Nazzaro, M; Rao, Sv; van't Hof, Aw; Omerovic, E; Uguccioni, L; Tamburino, C; Ferrari, F; Ceravolo, R; Tarantino, F; Casu, G; Mazzarotto, P; Cremonesi, A; Saia, F; Guiducci, V; Dellavalle, A; Curello, S; Mangiacapra, F; Evola, R; Liistro, F; Creaco, M; Colombo, A; Perkan, A; De Servi, S; Fischetti, D; Pucci, E; Romagnoli, E; Moretti, C; Moretti, L; Turturo, M; Bonmassari, R; Penzo, C; Loi, B; Mauro, C; Gabrielli, G; Micari, A; Petronio, As; Comeglio, M; Fresco, C; Pasquetto, G; Belloni, F; Amico, F. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 168:6(2014), pp. 838-845. [10.1016/j.ahj.2014.08.013]
Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program
Esposito, G;
2014
Abstract
Transradial intervention (TRI) and bivalirudin infusion compared with transfemoral coronary intervention or unfractionated heparin plus glycoprotein IIb/IIIa inhibitors decrease bleeding complications in patients with acute coronary syndromes (ACS). Although bleeding is thought to be associated with worse outcomes, it remains unclear whether TRI and bivalirudin both independently lower ischemic or combined ischemic and bleeding complications in ACS patients undergoing contemporary invasive management.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0002870314005547-main.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
457.5 kB
Formato
Adobe PDF
|
457.5 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
